These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7398982)

  • 21. [Letter: action of levamisole on the restoration of cellular immunity in man].
    Pasquier P; Vidal M; Couture J; Niel G; Floc'h F; Werner GH
    Nouv Presse Med; 1975 Nov; 4(38):2736. PubMed ID: 1105423
    [No Abstract]   [Full Text] [Related]  

  • 22. [Prevention of postoperative immunodepression with levamisole].
    Puppo F; Adami GF; Corsini G; Indiveri F; Zattoni J
    Minerva Anestesiol; 1981 Aug; 47(8):445-8. PubMed ID: 7312177
    [No Abstract]   [Full Text] [Related]  

  • 23. [Akne conglobata with immunodeficiency and its Levamisol treatment (author's transl)].
    Westphal HJ; Schütt C; Kaben U; Mattheus A
    Dermatol Monatsschr; 1981 Jul; 167(7):410-7. PubMed ID: 6456159
    [No Abstract]   [Full Text] [Related]  

  • 24. [A new approach to the therapy of pyoderma in servicemen: the use of the actoprotector bemitil].
    Samtsov AV; Tarasenko GN; Smirnov AV
    Voen Med Zh; 1998 May; 319(5):50-4, 96. PubMed ID: 9680838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levamisole in infectious diseases--a review of the literature.
    Brugmans J
    J Rheumatol Suppl; 1978; 4():115-21. PubMed ID: 104036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levamisole as an immunopotentiator for T cell deficiency.
    Taki HN; Schwartz SA
    Immunopharmacol Immunotoxicol; 1994 May; 16(2):129-37. PubMed ID: 8077602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pyoderma gangrenosum with altered cellular immunity and dermonecrotic factor.
    Delescluse J; De Bast C; Achten G
    Br J Dermatol; 1972 Dec; 87(6):529-32. PubMed ID: 4567639
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunostimulation in the treatment of decreased immunity].
    SarosieK J; Górska M; Bogdanikowa B; Waszkiel B; Jodczyk J
    Pol Tyg Lek; 1980 Jun; 35(23):877-8. PubMed ID: 7413510
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinico-immunological aspects of using levamisole in psychiatric practice].
    Semenov SF; Golodets RG; Avrutskiĭ GIa; Maksutova EL; Mogilina NP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):100-7. PubMed ID: 3364086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunocorrective therapy of pyoderma caused by staphylococci multiply resistant to antibiotics].
    Rodionov AN; Khavinson VKh; Barbinov VV
    Vestn Dermatol Venerol; 1990; (1):42-5. PubMed ID: 2327170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and electron microscopy evaluation of therapeutic effectiveness in chronic pyoderma using antibiotics in combination with dekaris (levamisole)].
    Kalamkarian AA; Delektorskiĭ VV; Padarian GN; Voskresenskaia GA
    Vestn Dermatol Venerol; 1982 Jun; (6):4-10. PubMed ID: 7124107
    [No Abstract]   [Full Text] [Related]  

  • 32. Levamisole and immunotherapy: some theoretic and practical considerations and their relevance to human disease.
    Amery WK; Gough DA
    Oncology; 1981; 38(3):168-81. PubMed ID: 7010258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cellular immunity in patients with ulcerous forms of chronic pyoderma undergoing treatment].
    Mazina NM; Baltabaev MK
    Vestn Dermatol Venerol; 1989; (3):48-51. PubMed ID: 2741546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levamisole therapy for HBsAg-positive chronic liver disease.
    Chadwick RG; Jain S; Cohen BJ; Scott GM; Thomas HC; Sherlock S
    Scand J Gastroenterol; 1980; 15(8):973-8. PubMed ID: 6972083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyoderma gangrenosum with IgA gammopathy.
    Murray JC
    Cutis; 1983 Nov; 32(5):477-80, 484-6. PubMed ID: 6360554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of levamisole on cellular immunity indices in chronic bronchitis and chronic pneumonia patients].
    Borisova AM; Novikova TA; Glazko AV
    Ter Arkh; 1984; 56(10):29-31. PubMed ID: 6335306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective immunoglobulin M (IgM) deficiency in two immunodeficient adults with recurrent staphylococcal pyoderma.
    Yocum MW; Strong DM; Chusid MJ; Lakin JD
    Am J Med; 1976 Apr; 60(4):486-94. PubMed ID: 1274982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pyoderma gangraenosum with special reference to immunologic and hematologic parameters].
    Warneke B; Breitbart EW; Nasemann T
    Z Hautkr; 1988 May; 63(5):398-408. PubMed ID: 3043950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.